Rankin E M, Hekman A, Hardeman M R, Hoefnagel C A
Br Med J (Clin Res Ed). 1984 Oct 27;289(6452):1097-100. doi: 10.1136/bmj.289.6452.1097.
The migration pattern of lymphocytes labelled with indium-111 was followed in a patient with B cell non-Hodgkin's lymphoma treated with a murine monoclonal anti-idiotype antibody. During the early phase of continuous infusion of antibody rapid fluxes of labelled lymphocytes into and out of the blood were seen. Dynamic scanning showed immediate uptake in the lungs; thereafter activity decreased in the lungs and increased in the liver. Studies of labelled and unlabelled cells in the circulation showed that treatment resulted in the removal of lymphocytes from the blood which was repopulated from an extravascular compartment. Tumour cells were shown to be cleared from the blood by the reticuloendothelial system in the liver. Indium-111 should be used circumspectly because it may cause chromosomal damage in labelled cells, but it is clearly useful as a radiolabel for following the migration pathways of lymphocytes in vivo.
在用鼠单克隆抗独特型抗体治疗的B细胞非霍奇金淋巴瘤患者中,追踪了用铟 - 111标记的淋巴细胞的迁移模式。在持续输注抗体的早期阶段,可见标记淋巴细胞快速进出血液。动态扫描显示肺部立即摄取;此后肺部活性降低,肝脏活性增加。对循环中标记和未标记细胞的研究表明,治疗导致血液中的淋巴细胞被清除,这些淋巴细胞由血管外隔室重新填充。肿瘤细胞被证明可通过肝脏中的网状内皮系统从血液中清除。铟 - 111应谨慎使用,因为它可能会导致标记细胞中的染色体损伤,但作为一种放射性标记物,它显然有助于追踪体内淋巴细胞的迁移途径。